Skip to content

Customers' Unmet Needs and Pains

Diagnostic Medicine in Brazil Current Pains Analysis

Unmet Needs and Pains

The Brazilian diagnostic medicine landscape, while experiencing significant growth in demand, presents a complex array of unmet needs and pain points for its diverse customer base. These challenges span issues of access, affordability, efficiency, and quality, impacting both individual patients (B2C) and organizational customers (B2B) such as health insurance operators, the public healthcare system (SUS), hospitals, clinics, and physicians.

For Patients (B2C Customers):

The most pressing unmet needs and pains for patients revolve around timely and equitable access to diagnostic services.

  • Limited Access and Long Waiting Times: A primary concern is the significant disparity in access to diagnostic services. This is particularly acute for patients reliant on the SUS, where long waiting times for appointments and procedures are common. Geographic disparities also play a crucial role, with individuals in remote or underserved areas facing greater difficulties in accessing services compared to those in urban centers. This directly translates to an unmet need for more accessible and promptly available diagnostic testing, regardless of socioeconomic status or location.
  • Affordability of Services: The cost of diagnostic services represents a substantial pain point. For patients in the self-pay segment or those with co-payments, the financial burden can be significant, especially for multiple or complex tests. This highlights an unmet need for more affordable diagnostic solutions and transparent pricing.
  • Restricted Access to Specialized/High-Complexity Tests: Patients in certain regions or within the SUS network often have limited access to advanced or highly specialized diagnostic tests. This lack of availability can impede accurate diagnosis and timely treatment, indicating an unmet need for broader dissemination of advanced diagnostic capabilities.
  • Fragmented Patient Data and Lack of Integration: Patients often experience a lack of seamless integration of their health data across different healthcare providers and diagnostic facilities. This can lead to the inconvenience of repeating tests, providing redundant information, and can hinder the continuity of care. The unmet need here is for integrated health information systems that allow for secure and efficient sharing of patient diagnostic history.
  • Desire for Patient-Centric Services: While not explicitly detailed as a "pain" in the provided texts, the broader industry trend towards patient-centricity implies an unmet need for services that are more convenient, communicative, and tailored to individual patient experiences (e.g., easier scheduling, clearer communication of results, more comfortable testing environments).

For B2B Customers:

B2B customers face a different set of challenges, primarily related to financial pressures, operational inefficiencies, and the need for reliable, high-quality diagnostic information.

  • Health Insurance Operators:
    • Rising Costs of Diagnostic Services: A major pain point is the increasing cost of diagnostic services, which constitute a significant portion of their expenditures (21.1% in 2023). There is an unmet need for cost-effective diagnostic solutions and partnerships that help manage these expenses without compromising care quality.
    • Pressure on Reimbursement Rates: While this is a pain for providers, it reflects the pressure operators are under to control costs. The negotiation of reimbursement rates is a constant challenge.
    • Complexity of Claims and Authorization: Bureaucratic processes for claims submission and authorization from providers create administrative burdens and potential for disputes (e.g., "glosas"). This signals an unmet need for streamlined and more efficient administrative interactions with diagnostic service providers.
  • Public Healthcare System (SUS):
    • Funding Constraints and Low Reimbursement Rates: The SUS grapples with significant funding limitations, which impact its ability to provide comprehensive and timely diagnostic services. The low reimbursement rates offered (Tabela SUS) make it difficult to contract with private providers to supplement capacity, leading to an unmet need for sustainable funding models and fair remuneration for services that can expand access.
    • Outdated Infrastructure and Capacity Issues: In some areas, public facilities may suffer from outdated infrastructure and insufficient capacity, contributing to long waiting times and limited service offerings. This reflects an unmet need for investment in public diagnostic infrastructure and resources.
  • Hospitals and Clinics:
    • Timely and Accurate Diagnostic Information: The core need is for reliable, accurate, and timely diagnostic results to support patient care. Delays or inaccuracies can severely impact treatment decisions.
    • Procurement of Equipment and Reagents: Hospitals and clinics, especially those with in-house labs, face challenges related to the cost and logistics of procuring diagnostic equipment and reagents, often exacerbated by import dependency. This points to an unmet need for more accessible and cost-effective supply chains for diagnostic technologies.
  • Physicians:
    • Access to Accurate and Timely Diagnostic Reports: Physicians require clear, concise, and clinically relevant diagnostic reports delivered promptly to make informed medical decisions.
    • Shortage of Specialized Professionals: A significant pain is the scarcity of specialized medical professionals, such as pathologists and radiologists, particularly in non-metropolitan areas. This can lead to delays in test interpretation and reporting, affecting the quality and timeliness of care. The unmet need is for greater availability of these specialists, potentially through training programs, telemedicine, or other innovative service delivery models.
  • Other Laboratories (Reference Services):
    • Reliable and Timely Reference Laboratory Services: Smaller laboratories that outsource specialized tests need access to dependable reference laboratory services that provide accurate results in a timely manner.

Overarching Unmet Needs:

Across both B2C and B2B segments, several overarching unmet needs emerge:

  • Improved Efficiency and Reduced Bureaucracy: Many pain points stem from inefficiencies in processes, whether in scheduling appointments, processing claims, or regulatory approvals.
  • Greater Adoption of Technology for Access and Efficiency: Technology, including telemedicine, digital health platforms, and AI-powered diagnostics, could address needs related to access, data integration, and professional shortages, but its adoption and integration face hurdles.
  • Enhanced Data Interoperability: The lack of seamless data exchange between different entities in the healthcare system is a pervasive issue that impacts patients, providers, and payers.
  • Better Value for Money: Whether it's patients seeking affordable tests or insurers managing costs, there's a clear demand for diagnostic solutions that offer better value, balancing quality, accessibility, and cost.

Addressing these unmet needs and alleviating these pain points is crucial for the continued development and improvement of the diagnostic medicine sector in Brazil, ultimately benefiting all stakeholders by enhancing the quality, accessibility, and efficiency of healthcare.

Key Findings

Customer Segment(s) Unmet Need / Pain Evidence / Source Report(s)
Patients (B2C) Limited Access & Long Waiting Times (especially in SUS and remote areas) Customer Challenges and Pains Analysis; Social Listening Analysis
Patients (B2C) Affordability of Services (self-pay, co-payments) Customer Challenges and Pains Analysis
Patients (B2C), SUS (B2B) Restricted Access to Specialized/High-Complexity Tests Customer Challenges and Pains Analysis
Patients (B2C), Physicians (B2B), Hospitals (B2B) Fragmented Patient Data / Lack of Seamless Data Integration Customer Challenges and Pains Analysis
Health Insurance Operators (B2B) Rising Costs of Diagnostic Services & Pressure on Reimbursement Customer Challenges and Pains Analysis; Social Listening Analysis; Current Demand Behavior Analysis (21.1% of expenses)
Health Insurance Operators (B2B) Complex and Bureaucratic Claims & Authorization Processes Customer Challenges and Pains Analysis
Public Healthcare System (SUS) (B2B) Funding Constraints & Low Reimbursement Rates (Tabela SUS) leading to access issues Customer Challenges and Pains Analysis; Social Listening Analysis
Public Healthcare System (SUS) (B2B) Outdated Infrastructure & Capacity Issues Customer Challenges and Pains Analysis
Hospitals and Clinics (B2B) Need for Timely & Accurate Diagnostic Information Customer Challenges and Pains Analysis
Hospitals/Clinics (B2B), Other Laboratories (B2B) High Cost/Difficulty in Procuring Equipment/Reagents (import dependency) Customer Challenges and Pains Analysis; Social Listening Analysis
Physicians (B2B interface) Shortage of Skilled Professionals (e.g., pathologists, radiologists) Final Customers Identification; Customer Challenges and Pains Analysis; Social Listening Analysis
All Segments Heavy Dependence on Imports (leading to cost and supply vulnerabilities) Social Listening Analysis (43.5% of medical devices/IVD market)
All Segments (indirectly) Regulatory Hurdles & Bureaucracy (e.g., ANVISA registration) Social Listening Analysis

References

  • Afip: Afip lança unidade de negócios de medicina diagnóstica. https://www.afip.com.br/afip-lanca-unidade-de-negocios-de-medicina-diagnostica/
  • Associação Brasileira de Medicina Diagnóstica (Abramed): Pesquisa revela que brasileiros realizaram 2,4 bilhões de exames de diagnóstico em 2023. https://abramed.org.br/pesquisa-revela-que-brasileiros-realizaram-24-bilhoes-de-exames-de-diagnostico-em-2023/
  • Conrad: Perspectivas da medicina diagnóstica para 2025. https://conradweb.com.br/perspectivas-da-medicina-diagnostica-para-2025/
  • Estadão: Fusões e aquisições no setor de saúde disparam no 1º trimestre, diz PwC. https://www.estadao.com.br/economia/fusoes-e-aquisicoes-no-setor-de-saude-disparam-no-1-trimestre-diz-pwc/
  • FGV EAESP: Impacto Da Criação Da Associação Brasileira De Medicina Diagnóstica (Abramed) Como Estratégia De Competitividade No Setor Privado De Serviços Diagnósticos No Brasil. https://bibliotecadigital.fgv.br/dspace/handle/10438/18544
  • Futuro da Saúde: Medicina diagnóstica: o que esperar do setor nos próximos anos. https://futurodasude.com.br/medicina-diagnostica-o-que-esperar-do-setor/
  • Hospital São Paulo: Saúde Suplementar. https://hospitalsaopaulo.org.br/saude-suplementar
  • Interfarma: Medicina diagnóstica tem papel decisivo na saúde suplementar. https://interfarma.org.br/noticias/medicina-diagnostica-tem-papel-decisivo-na-saude-suplementar
  • Medicina SA: Mercado de dispositivos médicos e diagnóstico in-vitro cresceu 57,9%. https://medicinasa.com.br/mercado-dispositivos-medicos/
  • Mobilemed: Tendências e desafios da Medicina Diagnóstica. https://mobilemed.com.br/tendencias-e-desafios-da-medicina-diagnostica/
  • Mordor Intelligence: Tamanho do mercado de diagnóstico in vitro do Brasil e análise de ações – Tendências e previsões de crescimento (2024 - 2029). https://www.mordorintelligence.com/pt/industry-reports/brazil-in-vitro-diagnostics-market
  • Percepção de Valor em Serviços de Medicina Diagnóstica. https://www.saudebusiness.com/gestao/percepcao-de-valor-em-servicos-de-medicina-diagnostica
  • Revistas PUC-SP: O segmento da medicina diagnóstica no Brasil. https://revistas.pucsp.br/RFCMS/article/download/26500/18754/62758
  • Saúde Business: Medicina diagnóstica: perspectivas otimistas para o próximo ano. https://www.saudebusiness.com/gestao/medicina-diagnostica-perspectivas-otimistas-para-o-proximo-ano
  • Saúde Business: Fusões e aquisições no setor de saúde ganham impulso em 2024. https://www.saudebusiness.com/fusoes-e-aquisicoes/fusoes-e-aquisicoes-no-setor-de-saude-ganham-impulso-em-2024
  • Shift: Tendências na medicina diagnóstica para 2025: inovação, eficiência e foco no paciente. https://medical.shift.com.br/tendencias-medicina-diagnostica-2025/
  • Shopplab Notícias: O Mercado Brasileiro de Medicina Diagnóstica: um Panorama Atual. https://www.shopplab.com.br/blog/o-mercado-brasileiro-de-medicina-diagnostica-um-panorama-atual/
  • Terra: Com crescimento de 25%, fusões e aquisições no setor de saúde quebram recorde. https://www.terra.com.br/economia/com-crescimento-de-25-fusoes-e-aquisicoes-no-setor-de-saude-quebram-recorde,72a1619778a872bb3f2529c7d709520by1u7137k.html
  • Terra: Fusões e aquisições no setor de saúde devem crescer este ano, com foco regional, diz consultoria. https://www.terra.com.br/economia/fusao-e-aquisicao/fusoes-e-aquisicoes-no-setor-de-saude-devem-crescer-este-ano-com-foco-regional-diz-consultoria,5156b31a6f66c4244878f249604280cahc8432oq.html